High treatment completion and no discontinuations due to lack of efficacy observed across faster and slower switch strategies “While transitioning patients is common in schizophrenia, clinicians have ...
Doctors are now prescribing antipsychotic medications for various types of anxiety disorders, eating disorders, and personality disorders. Although individual patients may show improvement, there is ...
Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results